North Korea's Reconnaissance General Bureau is restructured as the Reconnaissance Information Bureau, enhancing intelligence capabilities against South Korea.

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.